Alberta’s premier says a decision this week by British health officials is in line with her government’s plans on transgender healthcare. Under a new policy, U.K. patients under the age of 18 will no longer be able to access puberty blockers unless they enroll in a clinical trial. That decision follows a four year review of published research, but critics say politics are at play. Heather Yourex-West reports.
Danielle Smith
Danielle Smith says U.K. decision to limit access to puberty blockers is example for Alberta
More Videos
-
B.C. and Alberta settle wine dispute
-
Stampede circuit in full swing as politics meet pancakes in Calgary
-
Danielle Smith hosts annual Premier’s Breakfast during Calgary Stampede
-
Alberta to opt out of federal dental plan by 2026
-
Alberta government dismantles energy ‘war room’
-
UCP government hits one year anniversary of mandate
You are viewing an Accelerated Mobile Webpage.
View Original Article